NFG
RIGL icon

Next Financial Group’s Rigel Pharmaceuticals RIGL Stock Holding History

Next Financial Group’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-245
Closed -$5K – 2353
2019
Q4 		$5K Buy
245
+50
+26% +$1.03K ﹤0.01% 1973
2019
Q3 		$4K Hold
195
– – ﹤0.01% 1965
2019
Q2 		$5K Hold
195
– – ﹤0.01% 1902
2019
Q1 		$5K Hold
195
– – ﹤0.01% 1270
2018
Q4 		$4K Hold
195
– – ﹤0.01% 1620
2018
Q3 		$6K Buy
+195
New +$5.85K ﹤0.01% 1129
2017
Q4 		– Sell
-195
Closed -$7K – 1149
2017
Q3 		$7K Hold
195
– – ﹤0.01% 1338
2017
Q2 		$5K Hold
195
– – ﹤0.01% 1559
2017
Q1 		$6K Buy
+195
New +$4.97K ﹤0.01% 1467

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Next Financial Group's RIGL Position: Q1 2020 in Review

Next Financial Group sold out of Rigel Pharmaceuticals (RIGL) in Q1 2020, closing a stake of 245 shares — an estimated $5K sold.

Next Financial Group first reported a position in RIGL in Q1 2017 and held it in 9 quarters. The position peaked at $7K in Q3 2017. 126 funds tracked by Wall St. Rank hold RIGL as of Q1 2020.

  • Next Financial Group reported no remaining Rigel Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Next Financial Group sold 245 Rigel Pharmaceuticals shares in Q1 2020, an estimated $5K.
  • Next Financial Group first reported a position in Rigel Pharmaceuticals in Q1 2017 and held it in 9 quarters.
  • Next Financial Group's Rigel Pharmaceuticals position peaked at $7K in Q3 2017.
  • 126 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2020.

Based on Next Financial Group's 13F filing for Q1 2020, filed 27 Apr 2020.